Bellerophon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BLPH and buy or sell other stocks, ETFs, and their options commission-free!

About BLPH

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. 

CEO
Craig R. Jalbert
CEOCraig R. Jalbert
Employees
Employees
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2009
Founded2009
Employees
Employees

BLPH Key Statistics

Market cap
146.80K
Market cap146.80K
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
67.09K
Average volume67.09K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.10
52 Week high$0.10
52 Week low
$0.01
52 Week low$0.01
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.